谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Tetravalent Death Receptor 5 (DR5) Agonist Ozekibart (INBRX-109) + FOLFIRI in 2L+ Colorectal Adenocarcinoma (CRC): Preliminary Results from a Phase 1 Study.

David Berz,Olatunji B. Alese,David S. Hong,Nehal J. Lakhani,Elena Elez,Manish R Sharma, Brianne O'Neill, Yang Li, Emily Piccione, James Kalabus, Josep Garcia, Lee P. Hartner,Christopher Hanyoung Lieu

Journal of Clinical Oncology（2025）

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要